Crestor Sales Data

Rank 4 Current sales rank, all
U.S. Pharmaceuticals.

Last updated: February 2014 (updated quarterly).
The following data shows Crestor U.S. retail sales in Q4 2013 compared to previous quarters.

Date Range Sales Rank Sales ($000) Units (000)
Q4 2013 4 (1) 4.53% 1.58%
Q3 2013 5 -1.17% -11.62%
Q2 2013 5 (1) -0.37% -0.83%
Q1 2013 4 (1) 1.59% -2.93%
Q4 2012 3 2.41% 0.88%
Q3 2012 3 (2) 10.74% 3.89%
Q2 2012 5 (2) 0.61% 2.80%
Q1 2012 7 (1) 2.35% -3.70%
Q4 2011 8 3.69% 4.62%
Q3 2011 8 -1.78% -0.46%
Q2 2011 8 (1) 2.32% 3.35%
Q1 2011 7

* Units refer to the number of packages sold.

Source: IMS Health (Midas). Please review our terms of use and attribution guidelines. Copyright - All rights reserved. Unauthorized use and/or duplication of this material without express written permission is strictly prohibited.

Related News

DateArticle
August 2, 2011Statins May Help Heart in Some Young Stroke Patients
July 15, 2011Crestor and Zocor Drugs Linked to Muscle Degeneration, Rhabdomyolysis
October 28, 2010Universal American Announces New Medicare Part D Benefit Making Lipitor and Crestor Available for Low or No Copay
December 16, 2009Favorable Vote from FDA Advisory Committee on Benefit/Risk of Crestor (rosuvastatin calcium) in JUPITER Study
December 16, 2009FDA Panel Backs New Use For Astrazeneca's Crestor
December 11, 2009FDA Confirms Benefits of Crestor In More Patients
March 29, 2009Statin Might Help Fight Blood Clots in Veins
January 13, 2009Millions More Americans Might Be Placed on Statins
November 9, 2008Statin Might Help More People Fight Heart Disease Than Thought
April 21, 2008Vytorin Coverage with Leading Health Plans Revisited - See Uptake of Generic Simvastatin and Crestor Without Need for Widespread Formulary Changes
Hide
(web4)